SRC and psoriasis: Crucially, S1PR3 inhibition reduced both Src and STAT3 activation in vivo (Fig. 7D), corroborating our in vitro findings and supporting the S1PR3–Src–STAT3 signaling axis as a key driver of psoriasis pathogenesis.